|
|
Volumn 91, Issue 9, 2004, Pages 1651-1655
|
|
Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
a
a
a
a
a
a
a
b
a
|
|
Author keywords
Carboplatin; DHA paclitaxel; Phase I; Taxane
|
|
Indexed keywords
CARBOPLATIN;
DOCOSAHEXAENOIC ACID;
DOCOSAHEXAENOIC ACID PLUS PACLITAXEL;
PACLITAXEL;
UNCLASSIFIED DRUG;
ADENOCARCINOMA;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONJUGATE;
DRUG HYPERSENSITIVITY;
DRUG RESPONSE;
DRUG STRUCTURE;
ESOPHAGUS CARCINOMA;
FATIGUE;
FEMALE;
FUNCTIONAL ASSESSMENT;
HUMAN;
LIVER TOXICITY;
LOWER ESOPHAGUS SPHINCTER ADENOCARCINOMA;
MALAISE;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
MAXIMUM TOLERATED DOSE;
NAUSEA;
NEUROPATHY;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SKIN TOXICITY;
SOLID TUMOR;
THROMBOCYTOPENIA;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AREA UNDER CURVE;
CARBOPLATIN;
COHORT STUDIES;
DISEASE PROGRESSION;
DOCOSAHEXAENOIC ACIDS;
FEMALE;
HUMANS;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASMS;
PACLITAXEL;
TIME FACTORS;
|
|
EID: 9144249673
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bjc.6602196 Document Type: Article |
|
Times cited : (24)
|
|
References (10)
|
